Glucotrack Prices $3M Offering at $2.04, Deep Discount to Market
GCTK has more than doubled off its 52-week low of $1.998 on elevated volume (23× avg).
Summary
Glucotrack priced a $3.1M best-efforts offering at $2.04 per share, a 50% discount to the $4.11 market price, with pre-funded warrants for most investors. The deal adds roughly 1.5M shares on a fully diluted basis, doubling the current float. This follows a string of dilutive financings and a reverse split in August; the company remains in a cash crisis with going concern doubt. The deep discount signals weak demand and will pressure the stock. Closing is expected September 25.
Updates
· SEC 8-K — The 8-K details the offering: 169,388 shares and pre-funded warrants for 1,350,220 shares at $2.04 per share, gross proceeds of $3.1 million, closing expected September 25, 2026.
At the time of this announcement, GCTK was trading at $4.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6M. The 52-week trading range was $2.00 to $136.29. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.